ES2157961T3 - Inhibicion del hirsutismo y la alopecia en mujeres. - Google Patents

Inhibicion del hirsutismo y la alopecia en mujeres.

Info

Publication number
ES2157961T3
ES2157961T3 ES94309471T ES94309471T ES2157961T3 ES 2157961 T3 ES2157961 T3 ES 2157961T3 ES 94309471 T ES94309471 T ES 94309471T ES 94309471 T ES94309471 T ES 94309471T ES 2157961 T3 ES2157961 T3 ES 2157961T3
Authority
ES
Spain
Prior art keywords
alopecia
women
hirsutism
inhibition
chem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94309471T
Other languages
English (en)
Inventor
George Joseph Cullinan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of ES2157961T3 publication Critical patent/ES2157961T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

UN METODO PARA INHIBIR EL HIRSUTISMO Y LA ALOPECIA EN MUJERES COMPRENDIENDO ADMINISTRAR A UNA MUJER EN LA NECESIDAD DE TRATAMIENTO UNA CANTIDAD EFECTIVA DE UN COMPONENTE QUE TIENE LA FORMULA (I) EN DONDE EN DONDE R1 Y R3 SON INDEPENDIENTEMENTE HIDROGENO, -CH3, (ALQUILO C1-C6)-CO O CO-AR, EN DONDE AR ES FENILO OPCIONALMENTE SUSTITUIDO; R2 ES SELECCIONADO DEL GRUPO QUE CONSTA DE PIRROLIDINA, HEXAMETILENEIMINO, Y PIPERIDINO; O UNA SAL ACEPTABLE FARMACEUTICAMENTE DE SU SOLVENTE.
ES94309471T 1993-12-21 1994-12-19 Inhibicion del hirsutismo y la alopecia en mujeres. Expired - Lifetime ES2157961T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/171,089 US5574048A (en) 1993-12-21 1993-12-21 Methods of inhibiting hirsutism and alopecia in women

Publications (1)

Publication Number Publication Date
ES2157961T3 true ES2157961T3 (es) 2001-09-01

Family

ID=22622479

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94309471T Expired - Lifetime ES2157961T3 (es) 1993-12-21 1994-12-19 Inhibicion del hirsutismo y la alopecia en mujeres.

Country Status (22)

Country Link
US (2) US5574048A (es)
EP (1) EP0659414B1 (es)
JP (1) JPH07215864A (es)
KR (1) KR950016728A (es)
CN (1) CN1107703A (es)
AT (1) ATE203406T1 (es)
AU (1) AU690162B2 (es)
CA (1) CA2138498A1 (es)
CZ (1) CZ321394A3 (es)
DE (1) DE69427807T2 (es)
DK (1) DK0659414T3 (es)
ES (1) ES2157961T3 (es)
GR (1) GR3036977T3 (es)
HU (1) HUT71479A (es)
IL (1) IL112040A0 (es)
NO (1) NO944920L (es)
NZ (1) NZ270171A (es)
PH (1) PH31440A (es)
PT (1) PT659414E (es)
RU (1) RU94044457A (es)
SI (1) SI0659414T1 (es)
ZA (1) ZA9410092B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965551A (en) 1996-02-21 1999-10-12 North Carolina State University Method of treating alopecia
TW442286B (en) * 1996-02-28 2001-06-23 Pfizer New therapeutic uses of estrogen agonists
IL120266A (en) 1996-02-28 2005-05-17 Pfizer Use of estrogen antagonists and estrogen agonists in the preparation of medicaments for inhibiting pathological conditions
ATE301129T1 (de) 1999-05-04 2005-08-15 Strakan Int Ltd Androgen glykoside und die androgenische aktivität davon
US20060263452A1 (en) * 2005-05-17 2006-11-23 Alwyn Dowell Topical composition containing essential oils
EP2459187B1 (en) 2009-07-29 2021-01-06 Olsen, Elise Compositions and methods for inhibiting hair growth

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4133814A (en) * 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
US4380635A (en) * 1981-04-03 1983-04-19 Eli Lilly And Company Synthesis of acylated benzothiophenes
US4859585A (en) * 1986-04-17 1989-08-22 Trustees Of Tufts College In-vitro methods for identifying compositions which are agonists and antagonists of estrogens
US5075321A (en) * 1987-03-24 1991-12-24 University Of Pennsylvania Methods of treating diseases characterized by interactions of IgG-containing immune complexes with macrophage Fc receptors using antiestrogenic benzothiophenes
US5395842A (en) * 1988-10-31 1995-03-07 Endorecherche Inc. Anti-estrogenic compounds and compositions
JP3157882B2 (ja) * 1991-11-15 2001-04-16 帝国臓器製薬株式会社 新規なベンゾチオフエン誘導体

Also Published As

Publication number Publication date
EP0659414B1 (en) 2001-07-25
HUT71479A (en) 1995-11-28
AU8155094A (en) 1995-06-29
NO944920D0 (no) 1994-12-19
US5574048A (en) 1996-11-12
CN1107703A (zh) 1995-09-06
NO944920L (no) 1995-06-22
RU94044457A (ru) 1996-10-10
IL112040A0 (en) 1995-03-15
US5686468A (en) 1997-11-11
EP0659414A2 (en) 1995-06-28
DK0659414T3 (da) 2001-09-24
ZA9410092B (en) 1996-06-19
CA2138498A1 (en) 1995-06-22
KR950016728A (ko) 1995-07-20
DE69427807T2 (de) 2001-12-06
SI0659414T1 (en) 2001-12-31
CZ321394A3 (en) 1995-08-16
NZ270171A (en) 1996-08-27
EP0659414A3 (en) 1995-09-06
GR3036977T3 (en) 2002-01-31
HU9403665D0 (en) 1995-02-28
JPH07215864A (ja) 1995-08-15
ATE203406T1 (de) 2001-08-15
PH31440A (en) 1998-11-03
AU690162B2 (en) 1998-04-23
DE69427807D1 (de) 2001-08-30
PT659414E (pt) 2001-11-30

Similar Documents

Publication Publication Date Title
GR3023537T3 (en) Inhibition of thrombin.
NO943879D0 (no) Hemming av endometriose
NO943878D0 (no) Hemming av uterinfibrose
DE69402165D1 (de) Hemmung von Seborrhoe und Akne
NO943875L (no) Hemming av angiogenese og angiogene sykdommer
ZA9410094B (en) Method of increasing libido in post-menopausal women
ES2162845T3 (es) Inhibicion de problemas del snc en mujeres postmenopausicas.
ES2157961T3 (es) Inhibicion del hirsutismo y la alopecia en mujeres.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 659414

Country of ref document: ES